Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis [PDF]
L.E. Burgers +6 more
openalex +1 more source
Temporomandibular disorders and neck disability in individuals with cervical disc herniation
Abstract The primary aim of this study was to investigate the prevalence and severity of temporomandibular disorders (TMDs), and temporomandibular joint (TMJ) pain in patients with cervical disc herniation. The secondary aim was to investigate the relationship between neck disability, neck pain, sociodemographic factors, TMD, and TMJ pain.
Turgay Altunalan +3 more
wiley +1 more source
The "Clinical Topics" from the Electronic Health Record of Patients with Rheumatoid Arthritis Before Initiating Targeted Therapies and Association with Future Treatment Course. [PDF]
Objective Rheumatoid arthritis (RA) is a heterogeneous disease, with patients experiencing varied disease courses and responses to treatment. The objective of this study was to apply topic modeling to RA patient electronic health record (EHR) data and determine (1) the clinical topics/subgroups in those with RA before initiation of a biologic/targeted ...
Tang J +8 more
europepmc +2 more sources
Recurrent fever, arthralgia and asymmetric genu varum of unexpected etiology [PDF]
Liliana Quaresma +3 more
openalex +1 more source
Ankle Magnetic Resonance Imaging in Juvenile Idiopathic Arthritis Versus Non-Juvenile Idiopathic Arthritis Patients with Arthralgia [PDF]
Monika Ostrowska +5 more
openalex +1 more source
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow +3 more
wiley +1 more source
Effective Single Twymeeg Administration for Elderly Patient with Type 2 Diabetes (T2D), Arthralgia and Depression as Common Medical Problems [PDF]
Masaki OKADA +4 more
openalex +1 more source
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source

